| Bid Price | 45.10p | High Price | 48.00p |
|---|
| Ask Price | 48.00p | Low Price | 46.00p |
|---|
| Open Price | 46.00p | Spread | 6.04% |
|---|
| Prev Close | 45.50p | Volume | 16,995 |
|---|
Benchmark Holdings PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 24, 2024 | 45.01 | 45.28 | 45.01 | 45.50 | 770 |
| Apr 23, 2024 | 45.90 | 46.00 | 44.61 | 46.00 | 18,774 |
| Apr 22, 2024 | 43.50 | 44.44 | 43.00 | 44.10 | 235,394 |
| Apr 19, 2024 | 42.90 | 43.50 | 42.40 | 43.50 | 334,274 |
| Apr 18, 2024 | 43.50 | 43.50 | 43.01 | 43.25 | 40 |
Benchmark Holdings PLC Information
| Name | Benchmark Holdings PLC | Index | |
|---|
| ISIN | GB00BGHPT808 | Epic | BMK |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | AMSM |
|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
|---|
| EMS | 7,500 | Trading Status | Post Trading |
|---|
| Shares in Issue | 739.67 m | Prev Close | 45.50p |
|---|
| PE Ratio | | Market Cap | £355.04 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.015236 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.072802 | Quick Ratio | 1.330558 |
|---|
Benchmark Holdings PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 02/03/23 | BUY | Yngve Myhre | NED | 200,000 @ £0.38 | £76,700.00 |
| 15/12/22 | PLAC | Laura Lavers | RES | 530,000 @ 4.50 NOK | 2,385,000.00 NOK |
| 23/05/22 | BUY | Trond Williksen | CEO | 50,000 @ £0.50 | £25,100.00 |
| 20/05/22 | BUY | Yngve Myhre | NED | 9,469 @ £0.45 | £4,214.00 |
| 20/05/22 | BUY | Yngve Myhre | NED | 66,932 @ £0.45 | £29,785.00 |
Benchmark Holdings PLC News
